Literature DB >> 19765563

Marine compound Xyloketal B protects PC12 cells against OGD-induced cell damage.

Jia Zhao1, Ling Li, Chen Ling, Jie Li, Ji-Yan Pang, Yong-Cheng Lin, Jie Liu, Ruxun Huang, Guan-Lei Wang, Zhong Pei, Jinsheng Zeng.   

Abstract

Xyloketal B is a novel marine compound with unique chemical structure isolated from mangrove fungus Xylaria sp. (no. 2508). Recently, we have demonstrated that Xyloketal B is an antioxidant and can protect against oxidized low density lipoprotein (LDL)-induced cell injury. In the present study, we investigated whether Xyloketal B can protect against ischemia-induced cell injury in an in vitro oxygen glucose deprivation (OGD) model of ischemic stroke in PC12 cells. We found that Xyloketal B could directly scavenge 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical and protect PC12 cells against OGD insult. Furthermore, Xyloketal B alleviated OGD-induced mitochondria superoxide, mitochondria fragmentation and GTPase dynamin-related protein 1 (Drp1) overexpression as well as reduction of mitochondrial membrane potential. All together, the present study demonstrates that Xyloketal B protects PC12 cells against OGD-induced cell injury and that the anti-oxidative property and protective action on mitochondria may account for its neuroprotective actions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19765563     DOI: 10.1016/j.brainres.2009.09.034

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  19 in total

1.  Biomimetic peptides protect cells from oxidative stress.

Authors:  Chen Zhang; Yue Zhou; Guo-Yuan Yang; Song Li
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  Overexpression of HIF-1α protects PC12 cells against OGD/R-evoked injury by reducing miR-134 expression.

Authors:  Hongliang Zhang; Xianming Liu; Fengyu Yang; Dekui Cheng; Wei Liu
Journal:  Cell Cycle       Date:  2020-04-08       Impact factor: 4.534

3.  Xyloketal B exerts antihypertensive effect in renovascular hypertensive rats via the NO-sGC-cGMP pathway and calcium signaling.

Authors:  Li-Yan Zhao; Jie Li; Xiong-Qing Huang; Guo-Hao Wang; Xiao-Fei Lv; Wei-Feng Meng; Wen-Liang Chen; Ji-Yan Pang; Yong-Cheng Lin; Hong-Shuo Sun; Guan-Lei Wang; Yao-Min Du
Journal:  Acta Pharmacol Sin       Date:  2018-03-29       Impact factor: 6.150

4.  Xyloketal B alleviates cerebral infarction and neurologic deficits in a mouse stroke model by suppressing the ROS/TLR4/NF-κB inflammatory signaling pathway.

Authors:  Ni Pan; Liu-Yi Lu; Mei Li; Guo-Hao Wang; Fang-Yun Sun; Hong-Shuo Sun; Xue-Jun Wen; Jian-Ding Cheng; Jian-Wen Chen; Ji-Yan Pang; Jie Liu; Yong-Yuan Guan; Li-Yan Zhao; Wen-Liang Chen; Guan-Lei Wang
Journal:  Acta Pharmacol Sin       Date:  2017-05-29       Impact factor: 6.150

5.  Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study.

Authors:  Junhui Su; Cui Chang; Qi Xiang; Zhi-Wei Zhou; Rong Luo; Lun Yang; Zhi-Xu He; Hongtu Yang; Jianan Li; Yu Bei; Jinmei Xu; Minjing Zhang; Qihao Zhang; Zhijian Su; Yadong Huang; Jiyan Pang; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2014-12-12       Impact factor: 4.162

6.  Mitochondrial dynamics associated with oxygen-glucose deprivation in rat primary neuronal cultures.

Authors:  Edina A Wappler; Adam Institoris; Somhrita Dutta; Prasad V G Katakam; David W Busija
Journal:  PLoS One       Date:  2013-05-02       Impact factor: 3.240

7.  Xyloketal B attenuates atherosclerotic plaque formation and endothelial dysfunction in apolipoprotein e deficient mice.

Authors:  Li-Yan Zhao; Jie Li; Feng Yuan; Mei Li; Quan Zhang; Yun-Ying Huang; Ji-Yan Pang; Bin Zhang; Fang-Yun Sun; Hong-Shuo Sun; Qian Li; Lu Cao; Yu Xie; Yong-Cheng Lin; Jie Liu; Hong-Mei Tan; Guan-Lei Wang
Journal:  Mar Drugs       Date:  2015-04-14       Impact factor: 5.118

8.  Involvement of Kv1.5 protein in oxidative vascular endothelial cell injury.

Authors:  Wen-Liang Chen; Xiong-Qing Huang; Li-Yan Zhao; Jie Li; Jian-Wen Chen; Ying Xiao; Yun-Ying Huang; Jie Liu; Guan-Lei Wang; Yong-Yuan Guan
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

9.  Xyloketal B exhibits its antioxidant activity through induction of HO-1 in vascular endothelial cells and zebrafish.

Authors:  Zhen-Xing Li; Jian-Wen Chen; Feng Yuan; Yun-Ying Huang; Li-Yan Zhao; Jie Li; Huan-Xing Su; Jie Liu; Ji-Yan Pang; Yong-Cheng Lin; Xi-Lin Lu; Zhong Pei; Guan-Lei Wang; Yong-Yuan Guan
Journal:  Mar Drugs       Date:  2013-02-18       Impact factor: 5.118

10.  Xyloketal B suppresses glioblastoma cell proliferation and migration in vitro through inhibiting TRPM7-regulated PI3K/Akt and MEK/ERK signaling pathways.

Authors:  Wen-Liang Chen; Ekaterina Turlova; Christopher L F Sun; Ji-Sun Kim; Sammen Huang; Xiao Zhong; Yong-Yuan Guan; Guan-Lei Wang; James T Rutka; Zhong-Ping Feng; Hong-Shuo Sun
Journal:  Mar Drugs       Date:  2015-04-22       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.